drugset / Trial / NCT06562790
Study of Gamma PN3 in the Elderly
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Phase 1 double- blind randomised active comparator dose escalating study of Gamma PN3 in the elderly
Timeline
- Start
- 2024-08-26
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gamma-PN3 | Vaccine | 500 ug | Intramuscular |
| Subject | Gamma-PN3 | Vaccine | 1000 ug | Intramuscular |
| Subject | Gamma-PN3 | Vaccine | 1500 ug | Intramuscular |
| Comparator | Prevnar 13 | Vaccine | — | — |